CN106109881A - A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis - Google Patents
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis Download PDFInfo
- Publication number
- CN106109881A CN106109881A CN201610812331.4A CN201610812331A CN106109881A CN 106109881 A CN106109881 A CN 106109881A CN 201610812331 A CN201610812331 A CN 201610812331A CN 106109881 A CN106109881 A CN 106109881A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- medicine composition
- collaterals
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to technical field of Chinese medicine, purpose is a kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis according to the traditional Chinese medical science, obstruction of collaterals by blood stasis induced osteoporosis being recognized mechanism and providing, and each component of described Chinese medicine composition and mass parts ratio thereof are as follows: Herba Epimedii 5～15g, Placenta Hominis 4～8g, Radix Dipsaci 10～20g, Radix Polygoni Multiflori Preparata 15～25g, Radix Salviae Miltiorrhizae 8～16g, the Rhizoma Anemarrhenae 10～25g, Fructus Psoraleae 8～15g, Radix Rehmanniae 10～32g, the Cortex Eucommiae 15～26g；The medicine that the present invention provides is the Chinese prescription of a treating both the principal and secondary aspects of a disease.
Description
Technical field
The present invention relates to technical field of Chinese medicine, be specifically related to a kind of Chinese medicine treating obstruction of collaterals by blood stasis induced osteoporosis
Compositions, particularly for the field of Chinese medicine composition of obstruction of collaterals by blood stasis induced osteoporosis patient.
Background technology
Show according to medical literature: osteoporosis (osteoporosis) is the bone density and bone caused due to many reasons
Quality Down, bone micro-structure destroys, causes bone fragility to increase, thus is susceptible to the general osteopathia of fracture.Osteoporosis
It is divided into constitutional and the big class of Secondary cases two.Primary osteoporosis is divided into again postmenopausal osteoporosis (I type), senile bone
Matter osteoporosis (II type) and idiopathic osteoporosis (including juvenile) three kinds.Postmenopausal osteoporosis typically occurs in woman
Female's post menopausal 5～in 10 years；Senile osteoporosis refers generally to the osteoporosis that old man occurred after 70 years old；And idiopathic sclerotin
Loosening and occur mainly in teenager, the cause of disease is the most not clear.
So, just how to find a kind of Chinese medicine composition that can effectively treat above-mentioned obstruction of collaterals by blood stasis induced osteoporosis,
It it is our current problem in urgent need to solve.
Summary of the invention
Along with the development of China's Chinese medicine, on treatment obstruction of collaterals by blood stasis induced osteoporosis, people are gradually
The advantage appreciating Chinese traditional treatment above-mentioned obstruction of collaterals by blood stasis induced osteoporosis, and toxic and side effects is little over the course for the treatment of, take
By the advantage such as low, for the present situation of existing western medical treatment above-mentioned obstruction of collaterals by blood stasis induced osteoporosis, it is an object of the invention to
In providing a kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, to solve obstruction of collaterals by blood stasis induced osteoporosis
The most restorative problem of patient.This medicine is with common Chinese medicine as raw material, has instant effect, the feature such as evident in efficacy,
And can effectively treat above-mentioned obstruction of collaterals by blood stasis induced osteoporosis.
For reaching the purpose of foregoing invention, the technical solution adopted in the present invention is: provide one to treat obstruction of collaterals by blood stasis institute
Cause the Chinese medicine composition of osteoporosis, it is characterised in that each component of described Chinese medicine composition and mass parts ratio thereof are as follows
Shown in:
Herba Epimedii 5～15g, Placenta Hominis 4～8g, Radix Dipsaci 10～20g, Radix Polygoni Multiflori Preparata 15～25g, Radix Salviae Miltiorrhizae 8～16g, the Rhizoma Anemarrhenae 10～
25g, Fructus Psoraleae 8～15g, Radix Rehmanniae 10～32g, the Cortex Eucommiae 15～26g.
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described Chinese medicine composition
Each component and mass parts ratio as follows:
Herba Epimedii 10～13g, Placenta Hominis 6～7g, Radix Dipsaci 12～17g, Radix Polygoni Multiflori Preparata 18～22g, Radix Salviae Miltiorrhizae 10～14g, the Rhizoma Anemarrhenae 15～
22g, Fructus Psoraleae 10～13g, Radix Rehmanniae 15～28g, the Cortex Eucommiae 18～23g.
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described " preferred plan "
Each component of Chinese medicine composition and mass parts ratio as follows:
Herba Epimedii 12g, Placenta Hominis 6.5g, Radix Dipsaci 15g, Radix Polygoni Multiflori Preparata 20g, Radix Salviae Miltiorrhizae 13g, Rhizoma Anemarrhenae 20g, Fructus Psoraleae 12g, Radix Rehmanniae 25g,
Cortex Eucommiae 20g.
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described method include as
Lower step is prepared from:
A, above-mentioned raw materials Chinese medicine is picked decontamination and dust after, be ground into superfine end according to mass parts ratio stand-by；
B, the method preparing Chinese medicine capsules according to tradition, after being sieved by ground superfine myrrh thing, put in medicine device and mix
Uniformly, capsule (the sealed rear total length of its capsule is 23.3mm, medicated powder capacity 0.4～0.5g/ grain), Jin Erfen then it are prepared as
Dress seals.
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described instructions of taking is:
The capsule medicine prepared is taken with every twice-daily, sooner or later services once, dosage 2g/time, taking medicine before meal (send by warm water
Under), to take medicine 120～180 days, symptom gradually alleviates or fully recovers.
Each raw material Chinese medicine in prescription of the present invention all has detailed note in Chinese Pharmacopoeia, China's dictionary and China's book on Chinese herbal medicine
Carry.The present invention selects most common of which Chinese medicine to be raw material, gives full play to the pharmacological effect of each component:
Herba Epimedii, nature and flavor: Xin Gan, temperature, there is effect of kidney invigorating and YANG supporting, expelling wind and removing dampness, be used for treating sexual impotence do not lift, urine leaching
The disease such as drip, muscles and bones contraction urgency, hemiplegia, weakness of the waist and knees, rheumatic arthralgia, extremity are meciless；
Placenta Hominis, nature and flavor: Gan Xian, temperature, have QI invigorating, nourish blood, effect of benefit essence, be used for treating deficient, weakness and emaciation, consumptive fever hectic fever due to YIN-deficiency,
Cough with asthma, spitting of blood, night sweat, seminal emission, sexual impotence, women's vim and vigour are not enough, the infertile or newborn disease such as few；
Radix Dipsaci, nature and flavor: bitter in the mouth, pungent, slightly warm in nature, invigorating the liver and kidney, bone and muscle strengthening, blood circulation regulating, effect of only metrorrhagia, it is used for treating back acid
Bitterly, podomere flaccidity syndrome and arthralgia syndrome, fall and flutter wound, damage the diseases such as muscle folding bone, fetal movement red, the metrorrhagia of leakage, seminal emission, leukorrhagia, carbuncle skin ulcer be swollen；
Radix Polygoni Multiflori Preparata, nature and flavor: bitter sweet puckery, tepor, there is tonifying liver, kidney tonifying, effect of nourishing blood, dispeling the wind, be used for treating hepatic and renal YIN deficiency, sending out
Must early white, blood deficiency is dizzy, waist knee joint is weak, muscles and bones is ached, pass out semen, metrorrhagia and leukorrhagia, chronic malaria, chronic dysentery, chronic hepatitis, carbuncle, scrofula, intestinal
The disease such as wind, haemorrhoids；
Radix Salviae Miltiorrhizae, nature and flavor: bitter in the mouth, cold nature, there is blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving, nourishing blood to tranquillize the mind, effect of removing heat from blood eliminating carbuncle, be used for
Treatment menoxenia, dysmenorrhea, amenorrhea, the stagnant stomachache of the stasis of blood in puerperal, trusted subordinate's pain, lump in the abdomen, pyretic arthralgia swell and ache, traumatic injury,
Heat enters the diseases such as nutrient blood, dysphoria, vexed insomnia, ulcerative carbuncle toxic swelling；
The Rhizoma Anemarrhenae, nature and flavor: bitter in the mouth, cold in nature, there is clearing away heat-fire, nourshing Yin and drynsessmoistening prescription, effect of relieving restlessness of quenching the thirst, be used for treating epidemic febrile disease,
High hot excessive thirst, cough and asthma, cough caused by dryness, constipation, osteopyrexia and fever, restlessness of asrhenia type and insomnia, the diseases such as stranguria with turbid discharge of quenching one's thirst；
Fructus Psoraleae, nature and flavor: acrid in the mouth, hardship, warm in nature, there is reinforcing the kidney and supporting YANG, helping inspiration to relieve asthma, warming spleen and stopping diarrha effect, be used for treating kidney
YANG deficiency, below element deficiency and cold, chills and pain of the waist and kness, sexual impotence essence, frequent micturition, the enuresis, failure of the kidney in receiving QI, dyspnea due to deficiency are more than, asthenia of both the spleen and kidney, stool are long
Rush down, the disease such as vitiligo, alopecia areata, psoriasis；
Radix Rehmanniae, nature and flavor: sweet, cold, there is clearing away heat and cooling blood, yin nourishing, effect of promoting the production of body fluid, be used for treating in calentura crimson tongue excessive thirst, the deficiency of YIN
Heat, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, are spitted blood, epistaxis, send out the diseases such as speckle dermexanthesis；
The Cortex Eucommiae, nature and flavor: Gan Weixin, temperature, there is invigorating the liver and kidney, bone and muscle strengthening, antiabortive effect, be used for treating spinal column ache, foot knee joint flaccidity
Weak, dribbling urination, uncontrolled urination are itched, vaginal bleeding during pregnancy is intended to fall, the disease such as frequent fetal movement, hypertension.
Medicine of the present invention be differential diagnosis of diseases based on Chinese traditional treatment obstruction of collaterals by blood stasis induced osteoporosis with dialectical combine former
Then, think from pharmacological action and mechanism of action: with regard to obstruction of collaterals by blood stasis induced osteoporosis, each in medicine provided by the present invention
Raw material herbal medicine efficacy is played altogether, and above-mentioned disease is had good therapeutic effect.
Detailed description of the invention
The present invention is aiming at the treatment of above-mentioned obstruction of collaterals by blood stasis induced osteoporosis and a kind of Chinese medicine formula of proposing, adopts
The medicine effect prepared with this formula is good, and instant effect is the Chinese prescription of a treating both the principal and secondary aspects of a disease, is particularly suitable for Clinical practice.Under
Face combines the detailed description of the invention of the present invention and is described in further detail:
Embodiment 1:
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described Chinese medicine composition each
Individual component and mass parts ratio thereof are as follows:
Herba Epimedii 12g, Placenta Hominis 6.5g, Radix Dipsaci 15g, Radix Polygoni Multiflori Preparata 20g, Radix Salviae Miltiorrhizae 13g, Rhizoma Anemarrhenae 20g, Fructus Psoraleae 12g, Radix Rehmanniae 25g,
Cortex Eucommiae 20g.
Embodiment 2:
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described Chinese medicine composition each
Individual component and mass parts ratio thereof are as follows:
Herba Epimedii 13g, Placenta Hominis 7g, Radix Dipsaci 17g, Radix Polygoni Multiflori Preparata 22g, Radix Salviae Miltiorrhizae 14g, Rhizoma Anemarrhenae 22g, Fructus Psoraleae 13g, Radix Rehmanniae 28g, Du
Secondary 23g.
Embodiment 3:
A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described Chinese medicine composition each
Individual component and mass parts ratio thereof are as follows:
Herba Epimedii 15g, Placenta Hominis 8g, Radix Dipsaci 20g, Radix Polygoni Multiflori Preparata 25g, Radix Salviae Miltiorrhizae 16g, Rhizoma Anemarrhenae 25g, Fructus Psoraleae 15g, Radix Rehmanniae 32g, Du
Secondary 26g.
Model case:
Through clinical conditions obstruction of collaterals by blood stasis induced osteoporosis patient totally 200 example, the age is 135 examples of more than 70 years old, only
Having 65 examples is less than 70 years old.170 examples of recovery from illness in 200 example patients, 30 effective examples, total effective rate reaches 100%.After treatment, disease
Shape gradually alleviates or fully recovers.
Claims (3)
1. the Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis, it is characterised in that described Chinese medicine composition
Each component and mass parts ratio thereof are as follows:
Herba Epimedii 5～15g, Placenta Hominis 4～8g, Radix Dipsaci 10～20g, Radix Polygoni Multiflori Preparata 15～25g, Radix Salviae Miltiorrhizae 8～16g, the Rhizoma Anemarrhenae 10～
25g, Fructus Psoraleae 8～15g, Radix Rehmanniae 10～32g, the Cortex Eucommiae 15～26g.
The Chinese medicine composition for the treatment of obstruction of collaterals by blood stasis induced osteoporosis the most according to claim 1, it is characterised in that institute
Each component and the mass parts ratio thereof of stating Chinese medicine composition are as follows:
Herba Epimedii 10～13g, Placenta Hominis 6～7g, Radix Dipsaci 12～17g, Radix Polygoni Multiflori Preparata 18～22g, Radix Salviae Miltiorrhizae 10～14g, the Rhizoma Anemarrhenae 15～
22g, Fructus Psoraleae 10～13g, Radix Rehmanniae 15～28g, the Cortex Eucommiae 18～23g.
3., according to the Chinese medicine composition of the treatment obstruction of collaterals by blood stasis induced osteoporosis described in claim 1 to 2, its feature exists
In, each component of described Chinese medicine composition and mass parts ratio thereof are as follows:
Herba Epimedii 12g, Placenta Hominis 6.5g, Radix Dipsaci 15g, Radix Polygoni Multiflori Preparata 20g, Radix Salviae Miltiorrhizae 13g, Rhizoma Anemarrhenae 20g, Fructus Psoraleae 12g, Radix Rehmanniae 25g,
Cortex Eucommiae 20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610812331.4A CN106109881A (en) | 2016-09-09 | 2016-09-09 | A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610812331.4A CN106109881A (en) | 2016-09-09 | 2016-09-09 | A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106109881A true CN106109881A (en) | 2016-11-16 |
Family
ID=57271540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610812331.4A Withdrawn CN106109881A (en) | 2016-09-09 | 2016-09-09 | A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106109881A (en) |
-
2016
- 2016-09-09 CN CN201610812331.4A patent/CN106109881A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104474473B (en) | A kind of Chinese medicine composition for treating gynaecological imflammation and preparation method thereof | |
| CN106214932A (en) | A kind of Chinese medicine composition for treating kidney yang deficiency and Qi and blood deficiency | |
| CN103071105B (en) | External traditional Chinese medicinal preparation for treating threatened abortion and preparation method thereof | |
| CN103585453B (en) | One treats hypertensive Chinese medicine | |
| CN102973677A (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN103550539B (en) | Chinese medicinal composition for treating hypertension | |
| CN105688006A (en) | Traditional Chinese medicine composition for treating hemiplegia and preparation method thereof | |
| CN106109572A (en) | One treats osteoporotic Chinese medicine composition and preparation method thereof | |
| CN101703632B (en) | Chinese medicament for treating chronic hepatitis B | |
| CN105560842A (en) | Traditional Chinese medicine preparation for treating leucoderma caused by liver and kidney deficiency and wind-damp collateral blockage | |
| CN105726753A (en) | Chinese herbal medicine composition for treating sleeplessness and dreaminess caused by heart blood deficiency | |
| CN105456624A (en) | Traditional Chinese medicine caring composition for post-partum recovery and preparation method thereof | |
| CN105213968A (en) | A kind of foot bath preparation being used for the treatment of hysteromyoma and preparation method thereof | |
| CN104162026A (en) | Traditional Chinese medicine composition treating hypertension and preparation method thereof | |
| CN104958722A (en) | Dampness removing and arthralgia dispelling wine | |
| CN104623435A (en) | Soup capable of tonifying kidneys, tonifying qi and treating stranguria to treat ureteral obstruction | |
| CN106109881A (en) | A kind of Chinese medicine composition treating obstruction of collaterals by blood stasis induced osteoporosis | |
| CN104474125A (en) | Oral traditional Chinese medicine liquor for treating Sheehan's syndrome and preparation method of oral traditional Chinese medicine liquor | |
| CN104173897A (en) | Anti-aging traditional chinese medicine composition | |
| CN106109695A (en) | One can effectively treat osteoporotic pill medicine and preparation method thereof | |
| CN106177404A (en) | A kind of Chinese medicine composition treating the hepatic and renal YIN deficiency and preparation method thereof | |
| CN106266989A (en) | A kind of Chinese medicine composition for treating caused by energy stagnation and blood stasis hysteromyoma | |
| CN106214831A (en) | One treats leukodermic Chinese medicine for oral administration ball and preparation method thereof | |
| CN105688074A (en) | Decoction medicine for treating hypogastric pain and preparation method of decoction medicine | |
| CN105125860A (en) | Preparation for effectively treating osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161116 |
|
| WW01 | Invention patent application withdrawn after publication |